This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has minor subject area list
|
Adult; Aged; Aged, 80 and over; Benzamides; Female; Humans; Imatinib Mesylate; Interferon-alpha; Male; Middle Aged; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Treatment Outcome
|
|
information resource reference
|
Combination therapy of imatinib mesylate and interferon-alpha demonstrates minimal activity and significant toxicity in metastatic renal cell carcinoma: results of a single- institution phase II trial. Clin Genitourin Cancer. 2006 Mar; 4(4):275-80.
|
|
label
|
Combination therapy of imatinib mesylate and interferon-alpha demonstrates minimal activity and significant toxicity in metastatic renal cell carcinoma: results of a single- institution phase II trial.
|